Inventor · disambiguated record
Karl Kossen
Also filed as: KOSSEN KARL
10 granted patents·12 pending applications·75 citations·filing 2003–2016
87Inventor score
Top patents by PatentIndex Score
22 records- 0196US7728013B2Method of modulating stress-activated protein kinase systemINTERMUNE INC·Filed 2006·Granted Jun 1, 2010·40 cites·19 claims
- 0289US8741936B2Method of modulating stress-activated protein kinase systemBLATT LAWRENCE M·Filed 2012·Granted Jun 3, 2014·11 cites·5 claims
- 0388US8969347B2Compounds and methods for treating inflammatory and fibrotic disordersINTERMUNE INC·Filed 2012·Granted Mar 3, 2015·10 cites·22 claims
- 0483US9290450B2Compounds and methods for treating inflammatory and fibrotic disordersINTERMUNE INC·Filed 2014·Granted Mar 22, 2016·5 cites·27 claims
- 0582US8304413B2Compounds and methods for treating inflammatory and fibrotic disordersKOSSEN KARL·Filed 2009·Granted Nov 6, 2012·8 cites·19 claims
- 0674US9527816B2Method of modulating stress-activated protein kinase systemINTERMUNE INC·Filed 2014·Granted Dec 27, 2016·1 cites·24 claims
- 0763US10010536B2Method of modulating stress-activated protein kinase systemINTERMUNE INC·Filed 2016·Granted Jul 3, 2018·0 cites·4 claims
- 0861USRE47142ECompounds and methods for treating inflammatory and fibrotic disordersINTERMUNE INC·Filed 2014·Granted Nov 27, 2018·0 cites·19 claims
- 0956US2005209180A1RNA interference mediated inhibition of hepatitis C virus (HCV) expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 1055US2012046321A1Methods of treating atrial fibrillation with p38 inhibitor compoundsOLGIN JEFF·Filed 2011·Application pending·0 cites
- 1153US2005233998A1RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 1252US2010240704A1Method of modulating stress-activated protein kinase systemBLATT LAWRENCE M·Filed 2010·Application pending·0 cites
- 1352US2010029578A1Methods of Treating Atrial Fibrillation with P38 Inhibitor CompoundsOLGIN JEFF·Filed 2006·Application pending·0 cites
- 1451US2009047246A1Novel inhibitors of hepatitis c virus replicationINTERMUNE INC·Filed 2008·Application pending·0 cites
- 1550US9682071B2Methods of improving microvascular integrityINTERMUNE INC·Filed 2014·Granted Jun 20, 2017·0 cites·3 claims
- 1649US2010190731A1Methods for treating acute myocardial infarctions and associated disordersOLGIN JEFF·Filed 2010·Application pending·0 cites
- 1748US2004009510A1Allosteric nucleic acid sensor moleculesFiled 2003·Application pending·0 cites
- 1845US2011034495A1Method of Modulating Stress-Activated Protein Kinase SystemINTERMUNE INC·Filed 2006·Application pending·0 cites
- 1940US2012014917A1Methods of treating hiv patients with anti-fibroticsKOSSEN KARL·Filed 2011·Application pending·0 cites
- 2034US2013150426A1Methods of diagnosing and treating idiopathic pulmonary fibrosisINTERMUNE INC·Filed 2012·Application pending·0 cites
- 2133US9726677B2Proteomic IPF markersINTERMUNE INC·Filed 2014·Granted Aug 8, 2017·0 cites·12 claims
- 2233US2017314074A1Lpa-associated protein and rna expressionINTERMUNE INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Karl Kossen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →